Immunisation status during biologic therapy for hidradenitis suppurativa and psoriasis
Abstract Background The use of biologic agents has significantly improved the quality of life for patients with chronic skin diseases, and many other autoinflammatory diseases, over the past two decades. Due to the immunosuppressive nature of biologic agents, patients on these treatments are at incr...
Saved in:
Main Authors: | Corey Stone (Author), Tabrez Sheriff (Author), Yicong Liang (Author), Dédée F. Murrell (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case of Hidradenitis Suppurativa Responsive to Testosterone Replacement Therapy
by: Corey Stone, et al.
Published: (2024) -
Shedding light on the impact of hidradenitis suppurativa on women and their families: A focus of the International Journal of Women's Dermatology
by: Rishab Revankar, BS, et al.
Published: (2021) -
Outcomes of patients with chronic plaque psoriasis and hidradenitis suppurativa on biologic therapy during the Covid‐19 pandemic: A UK dermatology tertiary centre experience
by: S. Khan, et al.
Published: (2021) -
An assessment of the relative impact of hidradenitis suppurativa, psoriasis, and obesity on quality of life
by: M.A. Storer, MS, et al.
Published: (2018) -
A Case of Concurrent Psoriasis and Hidradenitis Suppurativa Successfully Treated with Tildrakizumab
by: Thomas Damsin
Published: (2023)